Gottlieb Outlines FDA’s Approach to Precision Medicines in Davos

Drug Industry Daily
A A
FDA Commissioner Scott Gottlieb spoke about the regulatory challenges of precision medicines and the agency’s plans to focus on durability and safety issues, in a panel discussion at the World Economic Forum in Davos, Switzerland.

To View This Article:

Login

Subscribe To Drug Industry Daily